| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PUBLIC LTD CO | Chief Development Officer | Feb 23, 2022 | |||
| TERN | Terns Pharmaceuticals, Inc. | Director | Jun 11, 2025 | |||
| VRDN | Viridian Therapeutics, Inc.\DE | Chief Medical Officer | Mar 10, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|